0000899243-22-008808.txt : 20220302
0000899243-22-008808.hdr.sgml : 20220302
20220302210104
ACCESSION NUMBER: 0000899243-22-008808
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220226
FILED AS OF DATE: 20220302
DATE AS OF CHANGE: 20220302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Munsch Frederick
CENTRAL INDEX KEY: 0001864367
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 22706431
MAIL ADDRESS:
STREET 1: 400 SOMERSET CORPORATE BLVD.
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-26
0
0000885590
Bausch Health Companies Inc.
BHC
0001864367
Munsch Frederick
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
NJ
08807
0
1
0
0
SVP, Controller and CAO
Common Shares, No Par Value
2022-02-27
4
M
0
3330
A
25748
D
Common Shares, No Par Value
2022-02-27
4
F
0
1318
24.35
D
24430
D
Common Shares, No Par Value
2022-02-26
4
F
0
306
24.35
D
24124
D
Common Shares, No Par Value
2022-02-27
4
F
0
334
24.35
D
23790
D
Restricted Share Units
2022-02-27
4
A
0
3330
A
2022-02-27
Common Shares, No Par Value
3330
0
D
Restricted Share Units
24.35
2022-02-27
4
M
0
3330
24.35
D
2022-02-27
Common Shares, No Par Value
0
0
D
Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer.
Each PSU converts into Common Shares on a one-for-one basis
This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs.
This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units ("RSUs").
This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of RSUs.
/s/ Christina Ackermann, attorney-in-fact
2022-03-02